158 related articles for article (PubMed ID: 459005)
21. Choices in creating continent urostomies following pelvic exenteration for gynecologic malignancies.
Silver DF; Ashwell TR
Gynecol Oncol; 2001 Sep; 82(3):510-5. PubMed ID: 11520148
[TBL] [Abstract][Full Text] [Related]
22. Reduction of mortality and morbidity associated with pelvic exenteration.
Karlen JR; Piver MS
Gynecol Oncol; 1975 Jun; 3(2):164-7. PubMed ID: 1183867
[No Abstract] [Full Text] [Related]
23. Pelvic exenteration: complications of urinary diversion.
Wrigley JV; Prem KA; Fraley EE
J Urol; 1976 Oct; 116(4):428-30. PubMed ID: 1053328
[TBL] [Abstract][Full Text] [Related]
24. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
Berek JS; Howe C; Lagasse LD; Hacker NF
Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
[TBL] [Abstract][Full Text] [Related]
25. Avoiding the Need for Bowel Anastomosis during Pelvic Exenteration-Urinary Sigmoid or Descending Colon Conduit-Short and Long Term Complications.
Alemozaffar M; Nam CS; Said MA; Patil D; Carney KJ; David S; Master VA
Urology; 2019 Jul; 129():228-233. PubMed ID: 30922975
[TBL] [Abstract][Full Text] [Related]
26. Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
Brown KG; Solomon MJ; Latif ER; Koh CE; Vasilaras A; Eisinger D; Sved P
J Surg Oncol; 2017 Mar; 115(3):307-311. PubMed ID: 27859276
[TBL] [Abstract][Full Text] [Related]
27. Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer.
Roos EJ; Van Eijkeren MA; Boon TA; Heintz AP
Int J Gynecol Cancer; 2005; 15(4):624-9. PubMed ID: 16014116
[TBL] [Abstract][Full Text] [Related]
28. Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies.
Ramirez PT; Modesitt SC; Morris M; Edwards CL; Bevers MW; Wharton JT; Wolf JK
Gynecol Oncol; 2002 May; 85(2):285-91. PubMed ID: 11972389
[TBL] [Abstract][Full Text] [Related]
29. Pelvic exenteration: surgical aspects and analysis of early and late morbidity in a series of 106 patients.
De Wever I
Acta Chir Belg; 2011; 111(5):273-81. PubMed ID: 22191127
[TBL] [Abstract][Full Text] [Related]
30. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
[TBL] [Abstract][Full Text] [Related]
31. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
32. Urinary conduit in pelvic cancer patients. A report of 16 years' experience.
Swan RW; Rutledge FN
Am J Obstet Gynecol; 1974 May; 119(1):6-13. PubMed ID: 4820911
[No Abstract] [Full Text] [Related]
33. Ileal conduit and continent ileocecal pouch for patients undergoing pelvic exenteration: comparison of complications and quality of life.
Forner DM; Lampe B
Int J Gynecol Cancer; 2011 Feb; 21(2):403-8. PubMed ID: 22964492
[TBL] [Abstract][Full Text] [Related]
34. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
[TBL] [Abstract][Full Text] [Related]
35. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
[TBL] [Abstract][Full Text] [Related]
36. Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations.
Lambrou NC; Pearson JM; Averette HE
Surg Oncol Clin N Am; 2005 Apr; 14(2):289-300. PubMed ID: 15817240
[No Abstract] [Full Text] [Related]
37. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
[TBL] [Abstract][Full Text] [Related]
38. Short-term outcomes after incontinent conduit for gynecologic cancer: comparison of ileal, sigmoid, and transverse colon.
Tabbaa ZM; Janco JM; Mariani A; Dowdy SC; McGree ME; Weaver AL; Cliby WA
Gynecol Oncol; 2014 Jun; 133(3):563-7. PubMed ID: 24704344
[TBL] [Abstract][Full Text] [Related]
39. Ileal conduit and continent ileocecal pouch for patients undergoing pelvic exenteration: comparison of complications and quality of life.
Forner DM; Lampe B
Int J Gynecol Cancer; 2011 Feb; 21(2):403-8. PubMed ID: 23077738
[TBL] [Abstract][Full Text] [Related]
40. Urological problems and the treatment of gynaecological cancer.
Davies Q; Luesley DM
Curr Opin Obstet Gynecol; 1998 Oct; 10(5):401-3. PubMed ID: 9818221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
